The new challenge focuses on computational methods for identifying blood gene expression signatures that can be used as markers of smoking exposure.
Sage is handling the initial data processing and cleaning for the consortium, while MSKCC is providing infrastructure for hosting the data.
The pharma company began funding the consortium in 2012 and will be involved with it for at least another five years.
The consortium will analyze data from patients and mouse models in the first year as part of efforts to find ways of detecting tumors earlier.
The initial phase of GENIE, which stands for Genomics, Evidence, Neoplasia, Information, Exchange, involves seven founding members and two informatics partners.
The Personalized Reproductive Medicine Initiative will investigate how an individual's genetic signature and personalized metrics affect overall fertility.
The consortium, a group formed by a number of participants in Oxford Nanopore's MinIon early-access program (MAP), plans to conduct a series of projects.
The database of genotype, phenotype, and clinical data from multi-drug resistant TB cases may support improved diagnostic development and clinical decision making.
Illumina is the latest to join the consortium, which is focused on personalizing cancer care.
The effort brings together gene banks, researchers, plant breeders, and big data experts, all of whom will use genomics to unlock crop diversity.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.